ISCO develop a parthenogenesis stem cell technology which could potentially avoid the limiting immune-response issues in regenerative medicine.
Browsing: Cognitive/neurodegenerative disorders
A study monitoring the brain activity of two patients with amyotrophic lateral sclerosis provides insight into how neurons control muscle movement in humans.
A novel PET scanning technique that utilizes an immune stimulant and a radioactive label has been demonstrated to accurately measure the immune response in the brain.
A novel population health management program for older adults has achieved significant health improvement for individuals with depression and reductions in stress for caregivers of dementia patients.
Arthur Roach, Research and Development Director at Parkinson’s UK, speaks to Neurology Central to discuss recent progress and current challenges involved in Parkinson’s research. In particular, we discuss the status of the anticipated glial cell-derived neurotrophic factor study.
Sporadic Creutzfeldt–Jakob disease (sCJD) is the most common form of human prion disease and is associated with a progressive cognitive…
This review discusses the future role of pharmacogenomics in the treatment of Alzheimer’s disease, and current opportunities.
Neurology Central talks to David Burn, Clinical Director at Parkinson’s UK, to discuss the recently launched Parkinson’s Excellence Network, and the future of Parkinson’s disease treatment and care in the UK.
Available to view on demand: the UC Davis research team present an update on preclinical development of their cell-gene therapy…
This commentary discusses the role of epigenomics in the neurodegeneration of ataxia-telangiectasia